Clinical Trials in Chicago

Showing 11321-11340 of 20,493 trials

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

NCT03861936

Based on the results of the Phase 2 Study 191622-130 \[NCT02010775\], the current Phase 2b study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of Masseter Muscle Prominence (MMP) in adults.

Masseter Muscle Prominence

Allergan150 participantsStarted May 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 22.2 miles

A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder

NCT00078754

This study will compare the medications fluoxetine (Prozac®) and divalproex (Depakote®) for the treatment of aggressive behavior in individuals with Intermittent Explosive Disorder (IED).

Intermittent Explosive Disorder

University of Chicago90 participantsStarted May 2003

Chicago, Illinois, United States

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder

Find Trials by Condition in Chicago

Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

Community Based DPP Program for Hispanic/Latino Females

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Post Approval Study of the remedē System

Heart Sounds Registry

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Corneal Collagen Cross-Linking for Ectasia (CXL)

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Global Anticoagulant Registry in the Field

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Managing Childhood Abdominal Pain

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)